Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2021:1321:211-228.
doi: 10.1007/978-3-030-59261-5_18.

Acute Respiratory Distress Syndrome and COVID-19: A Scoping Review and Meta-analysis

Mehdi Jafari-Oori  1 , Fatemeh Ghasemifard  2 , Abbas Ebadi  3 , Leila Karimi  3 , Farshid Rahimi-Bashar  4 , Tannaz Jamialahmadi  5   6 , Paul C Guest  7 , Amir Vahedian-Azimi  8 , Amirhossein Sahebkar  9   10   11   12
Affiliations
Meta-Analysis

Acute Respiratory Distress Syndrome and COVID-19: A Scoping Review and Meta-analysis

Mehdi Jafari-Oori et al. Adv Exp Med Biol. 2021.

Abstract

Acute respiratory distress syndrome (ARDS) is a fatal complication of the new severe acute respiratory syndrome coronavirus (SARS-CoV-2), which causes COVID-19 disease. This scoping review was carried out with international, peer-reviewed research studies and gray literature published up to July 2020 in Persian and English languages. Using keywords derived from MESH, databases including Magiran, IranMedex, SID, Web of Sciences, PubMed, Embase via Ovid, Science Direct, and Google Scholar were searched. After screening titles and abstracts, the full texts of selected articles were evaluated, and those which passed the criteria were analyzed and synthesized with inductive thematic analysis. Study quality was also evaluated using a standard tool. The overall prevalence of ARDS was estimated using a random-effects model. This led to identification of 23 primary studies involving 2880 COVID-19 patients. All articles were observational with a cross-sectional, retrospective, case report, and cohort design with moderate to strong quality. The main findings showed that COVID-19-related ARDS has a high prevalence and is different to ARDS due to other etiologies. Elderly and patients with comorbidities and organ failure should be closely surveyed for respiratory organ indications for several weeks after the onset of respiratory symptoms. There is currently no definitive treatment for ARDS in COVID-19 disease, and supportive therapies and their effects are somewhat controversial.

Keywords: Acute respiratory distress syndrome (ARDS); Covid-19; Meta-analysis; Scoping review.

PubMed Disclaimer

References

    1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223):497–506 - PubMed - PMC
    1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J et al (2019) A novel coronavirus from patients with pneumonia in China. N Engl J Med 382(8):727–733 - DOI
    1. Li X, Ma X (2020) Acute respiratory failure in COVID-19: is it “typical” ARDS? Crit Care 24(1):198. https://doi.org/10.1186/s13054-020-02911-9 - DOI - PubMed - PMC
    1. Goh KJ, Choong MC, Cheong EH, Kalimuddin S, Duu Wen S, Phua GC et al (2020) Rapid progression to acute respiratory distress syndrome: review of current understanding of critical illness from COVID-19 infection. Ann Acad Med Singap 49(1):1–9 - DOI
    1. Guan W, Ni Z, Hu Y, Liang W, Ou C, He J et al (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382(18):1708–1720 - DOI

LinkOut - more resources